Back to results
US 2010/0143292 A1Published application
Il-21 variants
AssigneeNovo Nordisk A/S
InventorsSiv Annegrethe Hjorth, Kent Bodensgaard, Dennis Madsen
Life of this patent
Estimating the term…
Abstract
IL-21 variants are provided wherein amino acids have been deleted in the region consisting of amino acid residues no. 65 to 98.
Claims13
1-23. (canceled)
An IL-21 peptide having a reduced amino acid region selected from the group consisting of:
- amino acid residues 66-98 in SEQ ID NO:2;
- amino acid residues 77-92 in SEQ ID NO:2;
- amino acid residues 83-90 in SEQ ID NO:2;
- amino acid residues 82-88 in SEQ ID NO:2;
- amino acid residues 71-92 in SEQ ID NO:2;
- amino acid residues 65-92 in SEQ ID NO:2;
- amino acid residues 77-96 in SEQ ID NO:2;
- amino acid residues 83-86 in SEQ ID NO:2;
- and
- amino acid residues 83-88 in SEQ ID NO:2.
7 more elements
Dependencies are inferred from the claim text.